Moxidectin for Blepharitis
What You Need to Know Before You Apply
What is the purpose of this trial?
A Single-Center, Investigator-Masked, Randomized, Placebo-Controlled, Investigator Initiated Study of the Safety and Efficacy of Moxidectin Tablets for the Reduction of Demodex Eyelash Infestation
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
Is moxidectin generally safe for humans?
How is the drug Moxidectin unique for treating blepharitis?
What data supports the effectiveness of the drug moxidectin for treating blepharitis?
Moxidectin has shown strong effectiveness in treating various parasitic infections in humans and animals, such as onchocerciasis and gastrointestinal nematodes, with significant reductions in parasite counts and long-lasting effects. While this data does not directly address blepharitis, it suggests moxidectin's potential as a powerful antiparasitic agent.111121314
Are You a Good Fit for This Trial?
This trial is for individuals with active blepharitis, characterized by eyelid inflammation and debris (collarettes) around the lashes. It's not suitable for those with other significant eye diseases.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive Moxidectin tablets or placebo for the reduction of Demodex eyelash infestation
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- Moxidectin
Find a Clinic Near You
Who Is Running the Clinical Trial?
Eye Research Foundation, Inc.
Lead Sponsor